Sumitomo Pharma Co., Ltd.
SMDPY · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,370 | $347,775 | $263,911 | $256,244 |
| - Cash | $261 | $20,453 | $23,116 | $85,393 |
| + Debt | $1,780 | $309,245 | $305,422 | $374,423 |
| Enterprise Value | $5,889 | $636,567 | $546,217 | $545,274 |
| Revenue | $808 | $108,002 | $105,649 | $112,434 |
| % Growth | -99.3% | 2.2% | -6% | – |
| Gross Profit | $499 | $63,890 | $65,978 | $70,995 |
| % Margin | 61.7% | 59.2% | 62.5% | 63.1% |
| EBITDA | $584 | $26,241 | $5,604 | $27,471 |
| % Margin | 72.3% | 24.3% | 5.3% | 24.4% |
| Net Income | $594 | $11,206 | $2,415 | $53,448 |
| % Margin | 73.6% | 10.4% | 2.3% | 47.5% |
| EPS Diluted | 1.5 | 28.21 | 6.08 | 134.53 |
| % Growth | -94.7% | 364% | -95.5% | – |
| Operating Cash Flow | $126 | -$1 | $11,009 | $939 |
| Capital Expenditures | -$7 | -$1,474 | -$2,375 | -$2,057 |
| Free Cash Flow | $118 | -$1,666 | $8,634 | -$1,118 |